Assenagon Asset Management S.A. Sarepta Therapeutics, Inc. Transaction History
Assenagon Asset Management S.A.
- $47.8 Billion
- Q3 2024
A detailed history of Assenagon Asset Management S.A. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 350,052 shares of SRPT stock, worth $45.6 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
350,052
Previous 359,696
2.68%
Holding current value
$45.6 Million
Previous $56.8 Million
23.07%
% of portfolio
0.09%
Previous 0.14%
Shares
19 transactions
Others Institutions Holding SRPT
# of Institutions
557Shares Held
85.8MCall Options Held
3.67MPut Options Held
1.75M-
Black Rock Inc. New York, NY10.3MShares$1.34 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.04MShares$1.18 Billion0.03% of portfolio
-
Capital International Investors Los Angeles, CA4.32MShares$563 Million0.14% of portfolio
-
State Street Corp Boston, MA4.14MShares$539 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.82MShares$497 Million0.33% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $11.4B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...